Biotechnology company that develops, validates, and commercializes software as prescription medical treatments
You can scroll over the chart's area to move in time and tap to see a specific date.
Highest Bid
$ 260.80
Lowest Offer
$ 188.50
Last Trade
$ 234.00
Live Orders
1,298
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Click Therapeutics is a biotechnology company that develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs.
Click Therapeutics Funding
Sign up to gain insights into Click Therapeutics funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series D | Apr 09, 2026 | 25M | ||
| Series D-1 | Apr 09, 2026 | 25M | ||
| Series C | Mar 17, 2025 | 9M | ||
| Series C | Mar 17, 2025 | 40M | ||
| Series B | May 20, 2024 | 3M | ||
| Series B | Oct 21, 2021 | 52M | ||
| Series A | Jun 15, 2018 | 17M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Click Therapeutics Management Team
Investors
Silicon Valley Bank
Sanofi Ventures
Ridgetop Health
Revelation Partners
K2 HealthVentures
Hikma Ventures
Health Catalyst Capital
Accelmed
Click Therapeutics Valuations & Financials
View real-time NPM data on Click Therapeutics stock including daily Click Therapeutics stock price estimates, valuation history, and historical share price information. Access Click Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Click Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Click Therapeutics? Get in touch to learn more.
Similar Companies
like Click Therapeutics
Neuron23
Health Care
Biotechnology company focused on developing personalized medicines for genetic disorders.
FAQ
We have answers
Click Therapeutics stock does not trade on public stock exchanges. Click Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Click Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Click Therapeutics Stock does not trade on public stock exchanges. In order to sell Click Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Nasdaq Private Market estimates that Click Therapeutics price per share was $6.6 as of May 14, 2026. This Click Therapeutics share value estimate (known as the NPM price) is based on market activity, publicly-sourced valuation data, and other proprietary information. With NPM Data and Intelligence premium for investors, you can get visibility into the Click Therapeutics share price today and the factors driving Click Therapeutics valuation estimates. Learn more about premium data here.
Read more about private company stock prices: Understanding the Bid-Ask Spread: How Buyers and Sellers Match on Price
There is no ticker symbol for Click Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Click Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Click Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Click Therapeutics is a private company and has not had an IPO. There is currently no Click Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Click Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
